Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Webb

Showing results (301-310 of 323) with videos related to

Pageof 33
Sort By:
Journal of Hypertension|November 10, 2017
Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of HypertensionGian Paolo Rossi, Teresa M Seccia, Matthias Barton, et al.
Journal of Hypertension|November 15, 2017
Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of HypertensionGian Paolo Rossi, Teresa M Seccia, Matthias Barton, et al.
Journal of Hypertension|January 12, 2005
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of HypertensionJohn Deanfield, Ann Donald, Claudio Ferri, et al.
Plos One|January 10, 2014
Prevalence and causes of prescribing errors: the PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training (PROTECT) studyCristín Ryan, Sarah Ross, Peter Davey, et al.
British Journal of Clinical Pharmacology|July 7, 2017
A call to incorporate systems theory and human factors into the existing investigation of harm in clinical research involving healthcare productsBrian D Edwards, Bernard Bégaud, Esther Daemen, et al.
Kidney International|April 17, 2016
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetesBoris B Betz, Sara J Jenks, Andrew D Cronshaw, et al.
Lancet (London, England)|April 14, 2009
The UK's NHS and pharma: need for more clinical pharmacologistsJeffrey K Aronson, David B Barnett, Alasdair M Breckenridge, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2016
Vasopressin Regulates Extracellular Vesicle Uptake by Kidney Collecting Duct CellsWilna Oosthuyzen, Kathleen M Scullion, Jessica R Ivy, et al.
Hypertension (Dallas, Tex. : 1979)|May 17, 2017
First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and DiuresisRobert W Hunter, Rebecca Moorhouse, Tariq E Farrah, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Circulating microRNAs as potential markers of human drug-induced liver injuryPhilip J Starkey Lewis, James Dear, Vivien Platt, et al.
Pageof 33

Showing results (301-310 of 323) with videos related to

Sort By:
Pageof 33
Journal of Hypertension|November 10, 2017
Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of HypertensionGian Paolo Rossi, Teresa M Seccia, Matthias Barton, et al.
Journal of Hypertension|November 15, 2017
Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of HypertensionGian Paolo Rossi, Teresa M Seccia, Matthias Barton, et al.
Journal of Hypertension|January 12, 2005
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of HypertensionJohn Deanfield, Ann Donald, Claudio Ferri, et al.
Plos One|January 10, 2014
Prevalence and causes of prescribing errors: the PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training (PROTECT) studyCristín Ryan, Sarah Ross, Peter Davey, et al.
British Journal of Clinical Pharmacology|July 7, 2017
A call to incorporate systems theory and human factors into the existing investigation of harm in clinical research involving healthcare productsBrian D Edwards, Bernard Bégaud, Esther Daemen, et al.
Kidney International|April 17, 2016
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetesBoris B Betz, Sara J Jenks, Andrew D Cronshaw, et al.
Lancet (London, England)|April 14, 2009
The UK's NHS and pharma: need for more clinical pharmacologistsJeffrey K Aronson, David B Barnett, Alasdair M Breckenridge, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2016
Vasopressin Regulates Extracellular Vesicle Uptake by Kidney Collecting Duct CellsWilna Oosthuyzen, Kathleen M Scullion, Jessica R Ivy, et al.
Hypertension (Dallas, Tex. : 1979)|May 17, 2017
First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and DiuresisRobert W Hunter, Rebecca Moorhouse, Tariq E Farrah, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Circulating microRNAs as potential markers of human drug-induced liver injuryPhilip J Starkey Lewis, James Dear, Vivien Platt, et al.
Pageof 33